Biohaven Shares Outstanding 2016-2022 | BHVN
Biohaven shares outstanding from 2016 to 2022. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Biohaven Annual Shares Outstanding
(Millions of Shares) |
| 2021 |
65 |
| 2020 |
59 |
| 2019 |
48 |
| 2018 |
39 |
| 2017 |
28 |
| 2016 |
13 |
| 2015 |
11 |
Biohaven Quarterly Shares Outstanding
(Millions of Shares) |
| 2022-09-30 |
39 |
| 2022-06-30 |
71 |
| 2022-03-31 |
70 |
| 2021-12-31 |
65 |
| 2021-09-30 |
39 |
| 2021-06-30 |
65 |
| 2021-03-31 |
62 |
| 2020-12-31 |
59 |
| 2020-09-30 |
60 |
| 2020-06-30 |
59 |
| 2020-03-31 |
56 |
| 2019-12-31 |
48 |
| 2019-09-30 |
52 |
| 2019-06-30 |
45 |
| 2019-03-31 |
44 |
| 2018-12-31 |
39 |
| 2018-09-30 |
40 |
| 2018-06-30 |
39 |
| 2018-03-31 |
37 |
| 2017-12-31 |
28 |
| 2017-09-30 |
36 |
| 2017-06-30 |
26 |
| 2017-03-31 |
13 |
| 2016-12-31 |
13 |
| 2016-09-30 |
13 |
| 2016-06-30 |
13 |
| 2016-03-31 |
12 |
| 2015-12-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.913B |
$0.463B |
|
Biohaven Ltd. is a clinical-stage biopharmaceutical company. It focuses on discovering and developing therapies for patients with debilitating neurological and neuropsychiatric diseases principally in the United States. Biohaven Ltd., formerly known as BIOHAVEN PHARM, is based in New Haven, Connecticut.
|
